NEXT Severe Cold, Flu and Sore Throate Night Max Strength is a Oral Solution in the Human Otc Drug category. It is labeled and distributed by Genomma Lab Usa Inc. The primary component is Acetaminophen; Dextromethorphan Hydrobromide; Doxylamine Succinate; Phenylephrine Hydrochloride.
Product ID | 50066-926_891fe403-1268-48c2-8933-d1d4a0bdf2bd |
NDC | 50066-926 |
Product Type | Human Otc Drug |
Proprietary Name | NEXT Severe Cold, Flu and Sore Throate Night Max Strength |
Generic Name | Acetaminophen, Dextromethorphan Hbr, Doxylamine Succinate, And Phenylephrine Hcl |
Dosage Form | Solution |
Route of Administration | ORAL |
Marketing Start Date | 2018-06-21 |
Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
Application Number | part341 |
Labeler Name | Genomma Lab USA Inc |
Substance Name | ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE |
Active Ingredient Strength | 650 mg/30mL; mg/30mL; mg/30mL; mg/30mL |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |